Salve Therapeutics, Inc.

SAN PEDRO, CA · Founded 2022 · Biotech · Private

A bioengineering platform for designing, modeling, and testing viral gene therapies

Claim this profile

Follows are private to you and power your alerts

Updated · salvetherapeutics.com

Sector
Biotech
Headquarters
SAN PEDRO, CA
Founded
2022
Latest Form D
$13K, May 2025
Total capital
$13K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$13K
1 Form D · last May 2025
18 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
1 pending

Capital timeline

2025FEDERAL ↑EQUITY ↓Cumulative $13K1st Form D$13K
2025FEDERAL ↑EQUITY ↓Cumulative $13K1st Form D$13K

Latest events

  • Private capital raisedForm D · SEC · 1st filing$13K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Stefan Nicholas LukianovExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 1
  • PendingWarfaref: A Digital Healthcare Mobile Application For Warfarin ManagementUSPTOApplication PCTUS2023072814
  • Validus Cellular Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
  • Variant BioSimilar federal contract value in Biotech · null in contracts
  • Therabene Inc.Similar federal contract value in Biotech · null in contracts
  • RHEUMAGEN, INC.Similar federal contract value in Biotech · null in contracts
  • BioLineRx Ltd.Similar federal contract value in Biotech · null in contracts
  • NANOPHARMACEUTICALS, LLCSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .